Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non‐cancer tissue

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The journal of obstetrics and gynaecology research

• Publication date

  2015-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jog.12808PMID 26554540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer stem cells and tumor metastasis

  2014cited by this paper
• NEDD4L Is Downregulated in Colorectal Cancer and Inhibits Canonical WNT Signaling

  2013influential reference
• Decreased expression of Nedd4L correlates with poor prognosis in gastric cancer patient

  2012influential reference
• Nedd4L modulates the transcription of metalloproteinase‐1 and ‐13 genes to increase the invasive activity of gallbladder cancer

  2011cited by this paper
• Transcription alterations of members of the ubiquitin–proteasome network in prostate carcinoma

  2011cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Benign, Proliferative Noninvasive (Borderline), and Invasive Epithelial Tumors of the Ovary

  2009cited by this paper
• Expression Profiles of Genes Involved in Poor Prognosis of Epithelial Ovarian Carcinoma: A Review

  2009cited by this paper
• Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia.

  2009cited by this paper
• Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007.

  2008cited by this paper
• Novel candidate targets of Wnt/β-catenin signaling in hepatoma cells

  2007cited by this paper
• Role of endocrine and growth factors on the ovarian surface epithelium

  2007cited by this paper
• Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.

  2007cited by this paper
• Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells.

  2006cited by this paper
• NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.

  2005cited by this paper
• NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor

  2005cited by this paper
• Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1.

  2004cited by this paper
• Smad4 Protein Stability Is Regulated by Ubiquitin Ligase SCFβ-TrCP1*

  2004cited by this paper
• Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer⋆

  2003cited by this paper
• Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells.

  2003cited by this paper
• DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.

  2002cited by this paper
• NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene

  2001cited by this paper
• Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.

  2001cited by this paper
• Smurf2 Is a Ubiquitin E3 Ligase Mediating Proteasome-dependent Degradation of Smad2 in Transforming Growth Factor-β Signaling* 210

  2000cited by this paper
• Hormonal regulation of physiological cell turnover and apoptosis

  2000cited by this paper
• Cancer statistics

  1989cited by this paper

• NEDD4 signaling: a new frontier in the diagnosis and treatment of breast and ovarian cancers

  2025cites this paper
• The SP1/NEDD4L Axis Suppresses the Breast Cancer Progression by Downregulating SNAI2 Expression.

  2025cites this paper
• NEDD4L Suppresses Proliferation and Promotes Apoptosis by Ubiquitinating RAC2 Expression and Acts as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma

  2024cites this paper
• NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progression

  2024cites this paper
• EGFR-T790M Mutation–Derived Interactome Rerouted EGFR Translocation Contributing to Gefitinib Resistance in Non-Small Cell Lung Cancer

  2023cites this paper
• NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor

  2023cites this paper
• NEDD4 E3 ubiquitin ligases: promising biomarkers and therapeutic targets for cancer.

  2023cites this paper
• NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation

  2022cites this paper
• NEDD4L suppresses PD-L1 expression and enhances anti-tumor immune response in A549 cells

  2022cites this paper
• Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer

  2022cites this paper
• Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response

  2021cites this paper
• Distinct associations of NEDD4L expression with genetic abnormalities and prognosis in acute myeloid leukemia

  2021cites this paper
• Autophagy of the m6A mRNA demethylase FTO is impaired by low-level arsenic exposure to promote tumorigenesis

  2021cites this paper
• Functional Significance of the E3 Ubiquitin Ligases in Disease and Therapeutics

  2021cites this paper
• Insights Into the Biological Role of NEDD4L E3 Ubiquitin Ligase in Human Cancers

  2021cites this paper
• Integrated bioinformatics analysis of the NEDD4 family reveals a prognostic value of NEDD4L in clear-cell renal cell cancer

  2021cites this paper
• The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance

  2021cites this paper
• Decreased expression of NEDD4L contributes to NSCLC progression and metastasis.

  2019cites this paper
• Differentially expressed tRFs in CD5 positive relapsed & refractory diffuse large B cell lymphoma and the bioinformatic analysis for their potential clinical use

  2019cites this paper
• Haplotype-resolved and integrated genome analysis of ENCODE cell line HepG2

  2018cites this paper
• Neural precursor cell-expressed developmentally down-regulated 4-like: a new biomarker in the pathophysiology of endometrial cancer

  2018cites this paper